Next Generation Left Atrial Appendage Implant to Treat Persistent Atrial Fibrillation

Project Information

AuriGen

Grant agreement ID: 823184

DOI 10.3030/823184

Project closed

EC signature date 26 June 2018

Start date 1 July 2018

End date 30 June 2021

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 3 503 093,40

EU contribution € 2 452 165,38

Coordinated by

AURIGEN MEDICAL LIMITED
Ireland

Deliverables

Other (2)

Sales Director Appointed
Operations Director Appointed

Documents, reports (2)

Clinical Study Report for CE Technical File
Pre-Clinical Study Report for CE Technical File

PreClinical Study Report for CE Technical File

Demonstrators, pilots, prototypes (1)

Marketing material prepared including website, brochures, press releases